arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CAPRICOR THERAPEUTICS, INC.

CAPR
$4.10 ▼ -0.08 (-2.03%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
21 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

CAPRICOR THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $190.6M
Dividend Yield
Revenue Growth N/M
Op. Margin None
ROIC -35.4%
FCF / Share $-1.56
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

21-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-105.04M
↓ -159.6%
Operating Margin Operating profit as % of sales
-191.1%
↓ -99.9%
FCF / Share Free cash flow per share
$-1.56
↓ -33.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
21
Cash Quality
48

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 21 years · 80 quarters